APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anorexiant Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Anorexiant Drug Industry Growth and Trends Forecast to 2032

27 December 2025102 pages

Choose your research edition.

Industry ResearchOral Anorexiant Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anorexiant Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Oral Anorexiant Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anorexiant Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anorexiant Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Oral Anorexiant Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Anorexiant Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Anorexiant Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anorexiant Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anorexiant Drug include Janssen Ortho, Teva Pharmaceuticals, Roche Pharmaceuticals, Recordati Rare Diseases, Patheon Pharmaceuticals, Novo Nordisk, MOVA Pharmaceuticals, Epic Pharma and Catalent Pharma Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Anorexiant Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Anorexiant Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Anorexiant Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Anorexiant Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Anorexiant Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Anorexiant Drug Market by Company

Janssen Ortho

Teva Pharmaceuticals

Roche Pharmaceuticals

Recordati Rare Diseases

Patheon Pharmaceuticals

Novo Nordisk

MOVA Pharmaceuticals

Epic Pharma

Catalent Pharma Solutions

Arena Pharmaceuticals

Akrimax Pharmaceuticals

Abbott Pharmaceuticals

Oral Anorexiant Drug Segment by Type

Catecholamines

Serotonin

Oral Anorexiant Drug Segment by Application

Clinics

Hospitals

Online Pharmacies

Retail Sales

Other

Oral Anorexiant Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anorexiant Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anorexiant Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anorexiant Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anorexiant Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Anorexiant Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Catecholamines Table 2. Major Company of Serotonin Table 3. Global Oral Anorexiant Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Oral Anorexiant Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral Anorexiant Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral Anorexiant Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Oral Anorexiant Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Oral Anorexiant Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral Anorexiant Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral Anorexiant Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral Anorexiant Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral Anorexiant Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Oral Anorexiant Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Oral Anorexiant Drug Industry Trends Table 25. Oral Anorexiant Drug Industry Drivers Table 26. Oral Anorexiant Drug Industry Opportunities and Challenges Table 27. Oral Anorexiant Drug Industry Restraints Table 28. Global Oral Anorexiant Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral Anorexiant Drug Revenue Market Share by Company (2021-2026) Table 30. Global Oral Anorexiant Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Oral Anorexiant Drug Sales Share by Company (2021-2026) Table 32. Global Oral Anorexiant Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Oral Anorexiant Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral Anorexiant Drug Major Company Production Sites and Headquarters Table 35. Global Oral Anorexiant Drug Company, Product Type & Application Table 36. Global Oral Anorexiant Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral Anorexiant Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral Anorexiant Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral Anorexiant Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Oral Anorexiant Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral Anorexiant Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral Anorexiant Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral Anorexiant Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Oral Anorexiant Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Oral Anorexiant Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral Anorexiant Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral Anorexiant Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral Anorexiant Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Oral Anorexiant Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Oral Anorexiant Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral Anorexiant Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral Anorexiant Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oral Anorexiant Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Oral Anorexiant Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral Anorexiant Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral Anorexiant Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral Anorexiant Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral Anorexiant Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Oral Anorexiant Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Janssen Ortho Company Information Table 72. Janssen Ortho Business Overview Table 73. Janssen Ortho Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Janssen Ortho Oral Anorexiant Drug Product Portfolio Table 75. Janssen Ortho Recent Development Table 76. Teva Pharmaceuticals Company Information Table 77. Teva Pharmaceuticals Business Overview Table 78. Teva Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Teva Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 80. Teva Pharmaceuticals Recent Development Table 81. Roche Pharmaceuticals Company Information Table 82. Roche Pharmaceuticals Business Overview Table 83. Roche Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Roche Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 85. Roche Pharmaceuticals Recent Development Table 86. Recordati Rare Diseases Company Information Table 87. Recordati Rare Diseases Business Overview Table 88. Recordati Rare Diseases Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Recordati Rare Diseases Oral Anorexiant Drug Product Portfolio Table 90. Recordati Rare Diseases Recent Development Table 91. Patheon Pharmaceuticals Company Information Table 92. Patheon Pharmaceuticals Business Overview Table 93. Patheon Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Patheon Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 95. Patheon Pharmaceuticals Recent Development Table 96. Novo Nordisk Company Information Table 97. Novo Nordisk Business Overview Table 98. Novo Nordisk Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novo Nordisk Oral Anorexiant Drug Product Portfolio Table 100. Novo Nordisk Recent Development Table 101. MOVA Pharmaceuticals Company Information Table 102. MOVA Pharmaceuticals Business Overview Table 103. MOVA Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. MOVA Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 105. MOVA Pharmaceuticals Recent Development Table 106. Epic Pharma Company Information Table 107. Epic Pharma Business Overview Table 108. Epic Pharma Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Epic Pharma Oral Anorexiant Drug Product Portfolio Table 110. Epic Pharma Recent Development Table 111. Catalent Pharma Solutions Company Information Table 112. Catalent Pharma Solutions Business Overview Table 113. Catalent Pharma Solutions Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Catalent Pharma Solutions Oral Anorexiant Drug Product Portfolio Table 115. Catalent Pharma Solutions Recent Development Table 116. Arena Pharmaceuticals Company Information Table 117. Arena Pharmaceuticals Business Overview Table 118. Arena Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Arena Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 120. Arena Pharmaceuticals Recent Development Table 121. Akrimax Pharmaceuticals Company Information Table 122. Akrimax Pharmaceuticals Business Overview Table 123. Akrimax Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Akrimax Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 125. Akrimax Pharmaceuticals Recent Development Table 126. Abbott Pharmaceuticals Company Information Table 127. Abbott Pharmaceuticals Business Overview Table 128. Abbott Pharmaceuticals Oral Anorexiant Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Abbott Pharmaceuticals Oral Anorexiant Drug Product Portfolio Table 130. Abbott Pharmaceuticals Recent Development Table 131. North America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 133. North America Oral Anorexiant Drug Sales Market Share by Country (2021-2026) Table 134. North America Oral Anorexiant Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Oral Anorexiant Drug Sales Market Share Forecast by Country (2027-2032) Table 136. North America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Oral Anorexiant Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Oral Anorexiant Drug Market Share by Country (2021-2026) Table 139. North America Oral Anorexiant Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Oral Anorexiant Drug Market Share Forecast by Country (2027-2032) Table 141. Europe Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 143. Europe Oral Anorexiant Drug Sales Market Share by Country (2021-2026) Table 144. Europe Oral Anorexiant Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Oral Anorexiant Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Oral Anorexiant Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Oral Anorexiant Drug Market Share by Country (2021-2026) Table 149. Europe Oral Anorexiant Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Oral Anorexiant Drug Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Oral Anorexiant Drug Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Oral Anorexiant Drug Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Oral Anorexiant Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Oral Anorexiant Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Oral Anorexiant Drug Market Share by Country (2021-2026) Table 159. Asia-Pacific Oral Anorexiant Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Oral Anorexiant Drug Market Share Forecast by Country (2027-2032) Table 161. Latin America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 163. Latin America Oral Anorexiant Drug Sales Market Share by Country (2021-2026) Table 164. Latin America Oral Anorexiant Drug Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Oral Anorexiant Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Oral Anorexiant Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Oral Anorexiant Drug Market Share by Country (2021-2026) Table 169. Latin America Oral Anorexiant Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Oral Anorexiant Drug Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Oral Anorexiant Drug Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Oral Anorexiant Drug Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Oral Anorexiant Drug Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Oral Anorexiant Drug Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Oral Anorexiant Drug Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Oral Anorexiant Drug Market Share by Country (2021-2026) Table 179. Middle East and Africa Oral Anorexiant Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Oral Anorexiant Drug Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Oral Anorexiant Drug Distributors List Table 184. Oral Anorexiant Drug Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Oral Anorexiant Drug Image Figure 2. Global Oral Anorexiant Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anorexiant Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anorexiant Drug Sales (2021-2032) & (K Units) Figure 5. Catecholamines Image Figure 6. Global Catecholamines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Serotonin Image Figure 8. Global Serotonin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Oral Anorexiant Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral Anorexiant Drug Market Share by Type 2025 VS 2032 Figure 11. North America Oral Anorexiant Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral Anorexiant Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral Anorexiant Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral Anorexiant Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral Anorexiant Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral Anorexiant Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral Anorexiant Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral Anorexiant Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral Anorexiant Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral Anorexiant Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral Anorexiant Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinics Image Figure 24. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Retail Sales Image Figure 30. Global Retail Sales Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Oral Anorexiant Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oral Anorexiant Drug Market Share by Application 2025 VS 2032 Figure 35. North America Oral Anorexiant Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Oral Anorexiant Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Oral Anorexiant Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Oral Anorexiant Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Oral Anorexiant Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Oral Anorexiant Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Oral Anorexiant Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Oral Anorexiant Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Oral Anorexiant Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Oral Anorexiant Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Oral Anorexiant Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Oral Anorexiant Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Oral Anorexiant Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral Anorexiant Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Oral Anorexiant Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Oral Anorexiant Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral Anorexiant Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Oral Anorexiant Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Oral Anorexiant Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral Anorexiant Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Oral Anorexiant Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oral Anorexiant Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral Anorexiant Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Oral Anorexiant Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oral Anorexiant Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Oral Anorexiant Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oral Anorexiant Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Oral Anorexiant Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Catecholamines
  • Serotonin
Applications
  • Clinics
  • Hospitals
  • Online Pharmacies
  • Retail Sales
  • Other
Companies covered
  • Janssen Ortho
  • Teva Pharmaceuticals
  • Roche Pharmaceuticals
  • Recordati Rare Diseases
  • Patheon Pharmaceuticals
  • Novo Nordisk
  • MOVA Pharmaceuticals
  • Epic Pharma
  • Catalent Pharma Solutions
  • Arena Pharmaceuticals
  • Akrimax Pharmaceuticals
  • Abbott Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Anorexiant Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Anorexiant Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Anorexiant Drug Market by Type
  6. 1.3.1 Catecholamines
  7. 1.3.2 Serotonin
  8. 1.4 Global Oral Anorexiant Drug Market Size by Type
  9. 1.4.1 Global Oral Anorexiant Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral Anorexiant Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral Anorexiant Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral Anorexiant Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral Anorexiant Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral Anorexiant Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral Anorexiant Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral Anorexiant Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Anorexiant Drug Industry Trends
  2. 2.2 Oral Anorexiant Drug Industry Drivers
  3. 2.3 Oral Anorexiant Drug Industry Opportunities and Challenges
  4. 2.4 Oral Anorexiant Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Anorexiant Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Anorexiant Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Anorexiant Drug Price (2021-2026)
  4. 3.4 Global Oral Anorexiant Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anorexiant Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Anorexiant Drug Company, Product Type & Application
  7. 3.7 Global Oral Anorexiant Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anorexiant Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anorexiant Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anorexiant Drug Tier 1, Tier 2, and Tier 3
4 Oral Anorexiant Drug Regional Status and Outlook
  1. 4.1 Global Oral Anorexiant Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Anorexiant Drug Historic Market Size by Region
  3. 4.2.1 Global Oral Anorexiant Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Anorexiant Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Anorexiant Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Anorexiant Drug Forecasted Market Size by Region
  7. 4.3.1 Global Oral Anorexiant Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Anorexiant Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Anorexiant Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Anorexiant Drug by Application
  1. 5.1 Oral Anorexiant Drug Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Retail Sales
  6. 5.1.5 Other
  7. 5.2 Global Oral Anorexiant Drug Market Size by Application
  8. 5.2.1 Global Oral Anorexiant Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Oral Anorexiant Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Oral Anorexiant Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Oral Anorexiant Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Oral Anorexiant Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Oral Anorexiant Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Oral Anorexiant Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Oral Anorexiant Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Ortho
  2. 6.1.1 Janssen Ortho Company Information
  3. 6.1.2 Janssen Ortho Business Overview
  4. 6.1.3 Janssen Ortho Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Ortho Oral Anorexiant Drug Product Portfolio
  6. 6.1.5 Janssen Ortho Recent Developments
  7. 6.2 Teva Pharmaceuticals
  8. 6.2.1 Teva Pharmaceuticals Company Information
  9. 6.2.2 Teva Pharmaceuticals Business Overview
  10. 6.2.3 Teva Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  12. 6.2.5 Teva Pharmaceuticals Recent Developments
  13. 6.3 Roche Pharmaceuticals
  14. 6.3.1 Roche Pharmaceuticals Company Information
  15. 6.3.2 Roche Pharmaceuticals Business Overview
  16. 6.3.3 Roche Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Roche Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  18. 6.3.5 Roche Pharmaceuticals Recent Developments
  19. 6.4 Recordati Rare Diseases
  20. 6.4.1 Recordati Rare Diseases Company Information
  21. 6.4.2 Recordati Rare Diseases Business Overview
  22. 6.4.3 Recordati Rare Diseases Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Recordati Rare Diseases Oral Anorexiant Drug Product Portfolio
  24. 6.4.5 Recordati Rare Diseases Recent Developments
  25. 6.5 Patheon Pharmaceuticals
  26. 6.5.1 Patheon Pharmaceuticals Company Information
  27. 6.5.2 Patheon Pharmaceuticals Business Overview
  28. 6.5.3 Patheon Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Patheon Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  30. 6.5.5 Patheon Pharmaceuticals Recent Developments
  31. 6.6 Novo Nordisk
  32. 6.6.1 Novo Nordisk Company Information
  33. 6.6.2 Novo Nordisk Business Overview
  34. 6.6.3 Novo Nordisk Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novo Nordisk Oral Anorexiant Drug Product Portfolio
  36. 6.6.5 Novo Nordisk Recent Developments
  37. 6.7 MOVA Pharmaceuticals
  38. 6.7.1 MOVA Pharmaceuticals Company Information
  39. 6.7.2 MOVA Pharmaceuticals Business Overview
  40. 6.7.3 MOVA Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MOVA Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  42. 6.7.5 MOVA Pharmaceuticals Recent Developments
  43. 6.8 Epic Pharma
  44. 6.8.1 Epic Pharma Company Information
  45. 6.8.2 Epic Pharma Business Overview
  46. 6.8.3 Epic Pharma Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Epic Pharma Oral Anorexiant Drug Product Portfolio
  48. 6.8.5 Epic Pharma Recent Developments
  49. 6.9 Catalent Pharma Solutions
  50. 6.9.1 Catalent Pharma Solutions Company Information
  51. 6.9.2 Catalent Pharma Solutions Business Overview
  52. 6.9.3 Catalent Pharma Solutions Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Catalent Pharma Solutions Oral Anorexiant Drug Product Portfolio
  54. 6.9.5 Catalent Pharma Solutions Recent Developments
  55. 6.10 Arena Pharmaceuticals
  56. 6.10.1 Arena Pharmaceuticals Company Information
  57. 6.10.2 Arena Pharmaceuticals Business Overview
  58. 6.10.3 Arena Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Arena Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  60. 6.10.5 Arena Pharmaceuticals Recent Developments
  61. 6.11 Akrimax Pharmaceuticals
  62. 6.11.1 Akrimax Pharmaceuticals Company Information
  63. 6.11.2 Akrimax Pharmaceuticals Business Overview
  64. 6.11.3 Akrimax Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Akrimax Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  66. 6.11.5 Akrimax Pharmaceuticals Recent Developments
  67. 6.12 Abbott Pharmaceuticals
  68. 6.12.1 Abbott Pharmaceuticals Company Information
  69. 6.12.2 Abbott Pharmaceuticals Business Overview
  70. 6.12.3 Abbott Pharmaceuticals Oral Anorexiant Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Pharmaceuticals Oral Anorexiant Drug Product Portfolio
  72. 6.12.5 Abbott Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Oral Anorexiant Drug Sales by Country
  2. 7.1.1 North America Oral Anorexiant Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Anorexiant Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Anorexiant Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Anorexiant Drug Market Size by Country
  6. 7.2.1 North America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Anorexiant Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Anorexiant Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Anorexiant Drug Sales by Country
  2. 8.1.1 Europe Oral Anorexiant Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Anorexiant Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Anorexiant Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Anorexiant Drug Market Size by Country
  6. 8.2.1 Europe Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Anorexiant Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Anorexiant Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Anorexiant Drug Sales by Country
  2. 9.1.1 Asia-Pacific Oral Anorexiant Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Anorexiant Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Anorexiant Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Anorexiant Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Anorexiant Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Anorexiant Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Anorexiant Drug Sales by Country
  2. 10.1.1 South America Oral Anorexiant Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Anorexiant Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Anorexiant Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Anorexiant Drug Market Size by Country
  6. 10.2.1 South America Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Anorexiant Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Anorexiant Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Anorexiant Drug Sales by Country
  2. 11.1.1 Middle East and Africa Oral Anorexiant Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Anorexiant Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Anorexiant Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Anorexiant Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Anorexiant Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Anorexiant Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Anorexiant Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Anorexiant Drug Value Chain Analysis
  2. 12.1.1 Oral Anorexiant Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Anorexiant Drug Production Mode & Process
  7. 12.2 Oral Anorexiant Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Anorexiant Drug Distributors
  10. 12.2.3 Oral Anorexiant Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst